Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, 350001, China.
Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, 350001, China.
BMC Cancer. 2023 Jun 9;23(1):529. doi: 10.1186/s12885-023-10893-4.
Pancreatic neuroendocrine tumors (PNETs) are one of the most common endocrine tumors, and liver metastasis (LMs) are the most common location of metastasis from PNETS; However, there is no valid nomogram to predict the diagnosis and prognosis of liver metastasis (LMs) from PNETs. Therefore, we aimed to develop a valid predictive model to aid physicians in making better clinical decisions.
We screened patients in the Surveillance, Epidemiology, and End Results (SEER) database from 2010-2016. Feature selection was performed by machine learning algorithms and then models were constructed. Two nomograms were constructed based on the feature selection algorithm to predict the prognosis and risk of LMs from PNETs. We then used the area under the curve (AUC), receiver operating characteristic (ROC) curve, calibration plot and consistency index (C-index) to evaluate the discrimination and accuracy of the nomograms. Kaplan-Meier (K-M) survival curves and decision curve analysis (DCA) were also used further to validate the clinical efficacy of the nomograms. In the external validation set, the same validation is performed.
Of the 1998 patients screened from the SEER database with a pathological diagnosis of PNET, 343 (17.2%) had LMs at the time of diagnosis. The independent risk factors for the occurrence of LMs in PNET patients included histological grade, N stage, surgery, chemotherapy, tumor size and bone metastasis. According to Cox regression analysis, we found that histological subtype, histological grade, surgery, age, and brain metastasis were independent prognostic factors for PNET patients with LMs. Based on these factors, the two nomograms demonstrated good performance in model evaluation.
We developed two clinically significant predictive models to aid physicians in personalized clinical decision-makings.
胰腺神经内分泌肿瘤(PNETs)是最常见的内分泌肿瘤之一,肝转移(LMs)是 PNETs 最常见的转移部位;然而,目前尚无有效的列线图来预测 PNETs 肝转移(LMs)的诊断和预后。因此,我们旨在开发一种有效的预测模型,以帮助医生做出更好的临床决策。
我们从 2010 年至 2016 年筛选了监测、流行病学和最终结果(SEER)数据库中的患者。通过机器学习算法进行特征选择,然后构建模型。根据特征选择算法构建了两个列线图,以预测 PNETs 发生 LMs 的预后和风险。然后,我们使用曲线下面积(AUC)、接收者操作特征(ROC)曲线、校准图和一致性指数(C-index)来评估列线图的区分度和准确性。Kaplan-Meier(K-M)生存曲线和决策曲线分析(DCA)也用于进一步验证列线图的临床疗效。在外部验证集中,也进行了相同的验证。
从 SEER 数据库中筛选出 1998 例经病理诊断为 PNET 的患者,其中 343 例(17.2%)在诊断时发生 LMs。PNET 患者发生 LMs 的独立危险因素包括组织学分级、N 分期、手术、化疗、肿瘤大小和骨转移。根据 Cox 回归分析,我们发现组织学亚型、组织学分级、手术、年龄和脑转移是 PNET 患者发生 LMs 的独立预后因素。基于这些因素,两个列线图在模型评估中表现良好。
我们开发了两个具有临床意义的预测模型,以帮助医生进行个性化的临床决策。